SEC Company Response from Lakewood-Amedex Biotherapeutics (LABT) — May 12, 2026
Lakewood-Amedex Biotherapeutics Inc.
Date: May 12, 2026 · CIK: 0002079272 · Accession: 0001213900-26-054931
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-295497
Letter
Re: Lakewood-Amedex Biotherapeutics Inc. Registration Statement on Form S-1 Filed May 1, 2026 File No. 333-295497 Acceleration Request: Requested Date: May 13, Requested Time: 4:00 P.M. Eastern Time
Dear Ms. Gama:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Lakewood-Amedex Biotherapeutics Inc. (the " Company ") hereby requests that the above-referenced Registration Statement on Form S-l (File No. 333-295497) (the " Registration Statement ") be declared effective on the "Requested Date" and at the "Requested Time" set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Lucosky Brookman LLP, by calling Scott Linsky at (732) 395-4408.
Thank you for your assistance in reviewing this filing. If you have any questions or comments regarding the foregoing, please contact Kelvin Cooper via email at kcooper@lakewoodamedex.com.
Very truly yours,
/s/ Kelvin Cooper
Show Raw Text
CORRESP 1 filename1.htm Lakewood-Amedex Biotherapeutics Inc. 8031 Cooper Creek Blvd, Unit 103 University Park, FL 34201 (941) 225-2515 May 12, 2026 Ms. Doris Stacey Gama U.S. Securities & Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Lakewood-Amedex Biotherapeutics Inc. Registration Statement on Form S-1 Filed May 1, 2026 File No. 333-295497 Acceleration Request: Requested Date: May 13, 2026 Requested Time: 4:00 P.M. Eastern Time Dear Ms. Gama: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Lakewood-Amedex Biotherapeutics Inc. (the " Company ") hereby requests that the above-referenced Registration Statement on Form S-l (File No. 333-295497) (the " Registration Statement ") be declared effective on the "Requested Date" and at the "Requested Time" set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Lucosky Brookman LLP, by calling Scott Linsky at (732) 395-4408. Thank you for your assistance in reviewing this filing. If you have any questions or comments regarding the foregoing, please contact Kelvin Cooper via email at kcooper@lakewoodamedex.com. Very truly yours, /s/ Kelvin Cooper Kelvin Cooper Chief Executive Officer Cc: Scott E. Linsky, Esq.